https://www.pharma-marketing.com/jason-graff-named-global-cco-of-vml-health/Pharma-Marketing.comen2026-06-17T10:49:15+00:00Jason Graff named Global CCO of VML Health https://www.pharma-marketing.com/de/jason-graff-wird-global-cco-bei-vml-health/Pharma-Marketing.comde2026-06-17T10:49:15+00:00Jason Graff wird Global CCO bei VML Health https://www.pharma-marketing.com/eva-alhnef-named-new-business-director-at-nisipharm/Pharma-Marketing.comen2026-06-17T09:31:44+00:00Eva Alhnef named new business director at NiSiPharm https://www.pharma-marketing.com/de/eva-alhnef-ist-neue-geschaeftsleiterin-bei-nisipharm/Pharma-Marketing.comde2026-06-17T09:31:43+00:00Eva Alhnef ist neue Geschäftsleiterin bei NiSiPharm https://www.pharma-marketing.com/america-cures-ad-highlights-early-u-s-access-to-medicines/Pharma-Marketing.comen2026-06-17T08:38:34+00:00“America Cures” ad highlights early U.S. access to medicines https://www.pharma-marketing.com/de/america-cures-neue-anzeige-betont-fruehen-zugang-zu-arzneimitteln/Pharma-Marketing.comde2026-06-17T08:38:34+00:00„America Cures“: Neue Anzeige betont frühen Zugang zu Arzneimitteln https://www.pharma-marketing.com/martin-kramer-becomes-new-chief-financial-officer-at-cheplapharm/Pharma-Marketing.comen2026-06-17T07:18:17+00:00Martin Krämer becomes new Chief Financial Officer at CHEPLAPHARM https://www.pharma-marketing.com/de/martin-kraemer-wird-neuer-chief-financial-officer-bei-cheplapharm/Pharma-Marketing.comde2026-06-17T07:18:17+00:00Martin Krämer wird neuer Chief Financial Officer bei CHEPLAPHARM https://www.pharma-marketing.com/johnson-johnson-invests-over-1-billion-in-jacksonville-vision-operations/Pharma-Marketing.comen2026-06-16T10:33:44+00:00Johnson & Johnson invests over $1 billion in Jacksonville vision operations https://www.pharma-marketing.com/de/johnson-johnson-investiert-ueber-1-milliarde-dollar-in-vision-standort-jacksonville/Pharma-Marketing.comde2026-06-16T10:33:43+00:00Johnson & Johnson investiert über 1 Milliarde Dollar in Vision-Standort Jacksonville https://www.pharma-marketing.com/gsk-to-acquire-nuvalent-in-10-6-billion-oncology-deal/Pharma-Marketing.comen2026-06-16T09:55:57+00:00GSK to acquire Nuvalent in $10.6 billion oncology deal https://www.pharma-marketing.com/de/gsk-will-nuvalent-fuer-106-milliarden-dollar-uebernehmen/Pharma-Marketing.comde2026-06-16T09:55:56+00:00GSK will Nuvalent für 10,6 Milliarden Dollar übernehmen https://www.pharma-marketing.com/germany-backs-away-from-variable-drug-discount-plan/Pharma-Marketing.comen2026-06-16T09:11:48+00:00Germany backs away from variable drug discount plan https://www.pharma-marketing.com/de/deutschland-rueckt-von-variablen-arzneirabatten-ab/Pharma-Marketing.comde2026-06-16T09:11:47+00:00Deutschland rückt von variablen Arzneirabatten ab https://www.pharma-marketing.com/kathrin-rezac-takes-over-brand-communications-at-reviderm/Pharma-Marketing.comen2026-06-16T08:54:14+00:00Kathrin Rezac takes over brand communications at Reviderm https://www.pharma-marketing.com/de/kathrin-rezac-uebernimmt-markenkommunikation-bei-reviderm/Pharma-Marketing.comde2026-06-16T08:54:13+00:00Kathrin Rezac übernimmt Markenkommunikation bei Reviderm